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Hydrogels that listen to cells: a review of
cell-responsive strategies in biomaterial
design for tissue regeneration
H. W. Ooi, S. Hafeez, C. A. van Blitterswijk, L. Moroni * and M. B. Baker *
The past decade has seen a decided move from static and passive biomaterials to biodegradable,
dynamic, and stimuli responsive materials in the laboratory and the clinic. Recent advances towards the
rational design of synthetic cell-responsive hydrogels—biomaterials that respond locally to cells or tissues
without the input of an artificial stimulus—have provided new strategies and insights on the use of artificial
environments for tissue engineering and regenerative medicine. These materials can often approximate
responsive functions of a cell’s complex natural extracellular environment, and must respond to the small
and specific stimuli provided within the vicinity of a cell or tissue. In the current literature, there are three
main cell-based stimuli that can be harnessed to create responsive hydrogels: (1) enzymes (2) mechanical
force and (3) metabolites/small molecules. Degradable bonds, dynamic covalent bonds, and non-covalent
or supramolecular interactions are used to provide responsive architectures that enable features ranging
from cell selective infiltration to control of stem-cell differentiation. The growing ability to spatio-
temporally control the behavior of cells and tissue with rationally designed responsive materials has the
ability to allow control and autonomy to future generations of materials for tissue regeneration, in addition
to providing understanding and mimicry of the dynamic and complex cellular niche.
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1. Introduction
A cell, and its niche, represents an instructive symphony of
complex interactions, feedback loops, and signals aimed at
controlling cellular behavior and function in real time. The cell’s
extracellular matrix (ECM), provides the cell a physical environ-
ment, a setting, to exist and communicate within. Made pre-
dominantly of proteoglycans and fibrous assemblies of
proteins, the ECM provides a multitude of functions, including
mechanical and structural support, spatio-temporal growth
factor presentation, traction and movement, and the ability to
remodel in response to a cell or external stimuli.1,2 Made from a
few key components, the responsiveness, instructiveness, and
variability of the ECM (with respect to different tissues and
organs) has long been a source of emulation. The recapitula-
tion, control, and amelioration of ECM–cell interactions all
remain significant targets for rationally designed systems.
Regenerative medicine aims to create therapies to replace or
regenerate cells, tissues, and organs towards the restoration
of impaired function resulting from genetic defects, disease,
trauma, or aging; tissue engineering focuses a bit more to apply
materials, cell biology, fabrication, and bioengineering strate-
gies to control the growth or regrowth of tissues from basic
cellular units, often progenitor cells.3,4 In both regenerative medicine
and tissue engineering, there is a large need to develop controllable
materials that recapitulate functions of the natural ECM,
including cell signaling, delivery of bioactives at controlled
rates, and tunable and responsive mechanical properties, yet
can still allow for regeneration and growth of the nascent
tissue. Viewing Nature as a source of inspiration, the materials
design within these fields focuses on mimicking features of a
cell’s natural environment.
Various three-dimensional (3D) scaffolds that share aspects
of the native ECM, including electrospun meshes,5–7 patterned
surfaces,8,9 and 3D printed scaffolds have been investigated;10–12
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however, hydrogels remain one of the most promising ECM
replacements. Hydrogels are made out of a 3D network of
crosslinked hydrophilic macromolecules, which possess the
ability to immobilize high amounts of water (ca. 90 to 499%).
The natural ECM, itself, is a hydrogel. Many of the individual
components of the ECM can form hydrogels (e.g. collagen,
elastin). Synthetic hydrogels are a natural choice for the creation
of artificial environments around cells.
The utilization of hydrogels for biomedical applications started
approximately 60 years ago, with the invention of contact lenses
from crosslinked poly(hydroxyethyl methacrylate) (PHEMA)
networks.13 Henceforth, hydrogels have played an increasingly
important role in the design of biomaterials for drug delivery,14–16
tissue engineering,15,17–20 and regenerative medicine.17,21 Although
a wide array of hydrogels have been investigated, ranging from
purely natural to purely synthetic polymers, each hydrogel holds
its own advantages and limitations. For example, naturally
derived hydrogels often provide desirable performance, but
are difficult to standardize and modify; synthetic hydrogels
are highly customizable, yet can be difficult to impart complex
mechanical properties and the correct bioactivity. Consequently,
the search for hydrogel systems that can best provide cells a
designed and controllable alternative microenvironment remains
an active area of research.
With significant progress in the field of polymer chemistry,
synthetic chemistry, and supramolecular chemistry, the capacity
to design and tailor polymer architecture and hydrogel networks
has advanced.22–24 No longer confined to synthesizing covalent
and static networks from conventional radical crosslinking
methods, current reports of instructive, stimuli responsive, and
biodegradable hydrogels bring closer the realization of complex
and dynamic systems that mimic ECM functions. Aligned with
these efforts, focus has been shifted to exploring different
chemistries to form dynamic hydrogels. Properties like cell-
mediated remodeling, cellular adhesion, growth factor release,
strain-stiffening, and viscoelasticity are being introduced through
the incorporation of cleavable bonds, reversible bonds, supra-
molecular bonds/polymers, self-assembly, or flexible polymer
backbones. Several excellent reviews on this current trend have
come out in the last few years.25–30
Dynamic hydrogel architectures have found success as
responsive materials to large external stimuli, yet they also
have the potential to produce responsive materials that act
biomimetically upon cues from a cell.31 For example, the ability
of a material to release growth factors in response to enzymes
from a nearby cell can be viewed as a significant advance
over a material relying entirely on external light irradiation.
Consequently, current efforts to sense and respond to cells have
quickly gained steam. As we obtain greater skill in rational
design and more insight into cellular behavior, we are on the
cusp of a new biomaterials revolution. Fully autonomous
hydrogels that can sense, respond, and influence cells aim to
become truly smart biomaterials of the future.
This review will delineate and focus attention to the growing
trend of cell responsiveness within the hydrogel and biomaterials
community. We have chosen to focus on systems designed for
tissue engineering and regenerative medicine; however, signif-
icant advances from other fields (e.g. drug delivery) will also be
presented with an eye towards their applications in regenera-
tive medicine. First, we will quickly introduce the main beha-
viors of a cell (inputs) that have been utilized to engineer such
responsive hydrogels. Secondly, we will briefly introduce the
prevalent chemistries used in the construction of such materials.
In the main body of this review, successful examples will be
broken down into three sections, namely enzyme responsive,
mechanical responsive, and metabolite/small-molecule respon-
sive hydrogels (Fig. 1). In conclusion, we will look forward at the
potential of cell responsive hydrogels and entertain the idea that
dynamic and responsive synthetic environments can bring us
close to the creation of an artificial ECM.
2. Cell outputs
The chemical makeup and manner in which the multicompo-
nent ECM is assembled directs cellular behavior. Reciprocally,
the responsive and weak interactions between the ECM com-
ponents create a dynamic environment that can respond to and
Fig. 1 Shown schematically are the three main strategies for the creation
of cell-responsive materials. Enzymatic catalysis (top center) of hydrogel
breakdown has been extensively used in tissue engineering to allow matrix
remodelability. By incorporating enzyme cleavable units into the hydrogel
structure (e.g. MMP cleavage sites, depicted in purple), cells are able to
infiltrate and migrate through the material via the action of enzymes
(depicted in yellow) cleaving the hydrogel network (blue fibers). Most
recently, mechanically responsive hydrogels (bottom left) have been
developed to allow for response based on a cell’s traction forces. Shown
schematically, a cell transfers traction forces to the matrix via integrins
(light blue), which can remodel or rearrange dynamic interactions in the
hydrogel, illustrated as the binding between a green cup and a red ball. Still
in their infancy, such materials heavily rely on dynamic covalent and
supramolecular interactions. Metabolite and small molecule responsive
(bottom right) hydrogels represent a broad class of materials that sense
and respond to small molecules, proteins, and metabolic by-products
around a cell or tissue. As an example, depicted are pH sensitive receptors
(orange) that become charged (light blue spheres). Such metabolite
responsive materials often rely on highly specific non-covalent interactions,
and are largely biohybrid type materials.
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influence the activities of a nearby cell.32 For example, the
spatio-temporal control of growth factors is a major role of the
ECM and regulates many in vivo processes. The ECM can
sequester transforming growth factor-b (TGFb) in an inactive
form, and release its active form in response to cellular traction
forces during tissue remodeling.33 Additionally, laminin cleavage
via matrix-metalloproteases (MMPs) has been shown to release
fragments capable of regulating stem cell differentiation.34
Numerous ECM components are released or presented in response
to cellular cues, such as mechanical force or protease activity.35
When designing materials aimed at mimicking such respon-
sive functions, it is crucial to understand what cues are both
produced by a living cell and have been shown to trigger
responsive materials. Shown schematically in Fig. 1, three main
cell outputs have been employed as stimuli in responsive
hydrogels: (1) enzymes, (2) mechanical force, and (3) metabolites/
small molecules.
2.1 Enzymes
The fundamental role of enzymes as catalysts is to increase the
rate of biochemical reactions. Enzymes are ubiquitous in living
systems,36 have high specificity for chemical transformations,
and maintain high activity under physiologic conditions,
making them ideal triggers for the chemical design of responsive
hydrogel systems. Furthermore, cells highly rely on enzymes for
the in vivo regulated remodeling of the natural ECM, a process
crucial for the maintenance of normal biological functions.2
Differences in enzyme expression is associated with many
events including stem-cell differentiation, tissue repair, and
pathological disorders. Altered expression level of specific
enzymes can be used to catalyze a reaction in hydrogels for
controlled release or degradation at desired sites or under
certain events.37,38
2.2 Mechanical force
In the last decade, extensive research has been carried out to
investigate the influence of mechanical forces generated
between cells and their environment. Researchers now have
developed understanding of the forces generated by cells in tissue
remodeling and cellular functions ranging from cell adhesion,
migration, proliferation, differentiation and morphogenesis.39–42
Generally, cells first sense the matrix and pull to deform
the matrix. These contractile forces are generated by actomyo-
sin contraction and are transmitted to the ECM via focal
adhesions—an integrin containing multi-protein complex con-
necting the cytoskeleton to the ECM. Cellular traction forces are
in the range of piconewtons to nanonewtons and occur at the
nanometer to micrometer length scale,43 yet the mechanical
feedback a cell receives from its environment can activate
specific signaling pathways or alter gene expression in a
surprisingly quick fashion.44 There are numerous reviews on
the complex interplay between a cell’s mechanical sensing
framework and its ECM environment.37,45–48 Only in the past
few years has this understanding been translated to materials
that can also alter their properties in response to the small
mechanical forces generated by a cell.
2.3 Metabolites and small molecules
Metabolites and small molecules produced (or consumed) by a
cell also offer the possibility to be used as a trigger for cell-
responsive systems. Metabolism (a set of chemical reactions
taking place within a cell) is very important for a cell to regulate
pathways and maintain critical concentrations of important
building blocks (and by-products) within and outside of a cell.
Any up and down regulation of these pathways leads to a
change in the extracellular environment. For example, changes
in the reductive power49 and pH around cancerous cells,50 higher
glucose levels in diabetic patients,51 and higher levels of reactive
oxygen species under stress52 have all been successfully utilized to
create responsive hydrogel systems. In natural systems, cell meta-
bolites are extensively used in signaling pathways, can initiate very
specific interactions, and can maintain integrity and activity
over long ranges. However, the difficulty and challenge lies in
translating the sensitivity, specificity, and amplification, of these
sometimes small differences to synthetic hydrogel systems.
3. Chemistries developed
The range of chemical structures and systems available to
engineer cell-responsive hydrogels is a limited, but growing,
set. Such chemistry must be reversible (or degradable), both
stable and responsive under physiologic conditions, syntheti-
cally accessible, and ultimately, cytocompatible. Although all
the systems described rely on water soluble macromolecules,
it is the incorporation of dynamic chemical units that provide
responsive function. To highlight the characteristics of avail-
able systems, employed approaches can be categorized into
five main chemical strategies. Shown schematically in Fig. 2,
cell-responsive materials mainly rely on pH responsiveness,
enzyme catalyzed bond breakage, dynamic covalent chemistry,
supramolecular interactions, and protein or DNA engineering.
One should note that often, more than one category is imple-
mented in more complex systems; the illustrative examples
herein have been classified according to the main strategy
employed.
3.1 pH responsive
The earliest hydrogel architectures to allow for responsive
biomaterials were pH responsive matrices. Such pH responsive
hydrogels normally contain amines (pKa 8–10) or acids (pKa 4–6)
that are protonated/deprotonated to form charges within the
hydrogel network. This change in protonation state introduces
swelling/deswelling due to changes in the ionic character of the
network. In a classic example, poly(acrylic acid) hydrogels swell
at higher pHs via formation of the ionic carboxylate. General
acid or base catalyzed hydrolysis of polymer backbones can also
be utilized for the creation of pH responsive materials.
Such pH responsive approaches have been extensively studied
for drug delivery,53 but often lack the sensitivity or specificity
needed for fine control in more complex applications. To over-
come this limitation, often pH responsive hydrogels are coupled
with enzymes that catalyze the conversion of a signal into an
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acidic (or basic) product and lowering (or rising) the local pH.
An example is the glucose/glucose oxidase (Glu/GOx) system
that produces gluconic acid. This type of pH responsive hydro-
gel has been used extensively for glucose responsive and insulin
releasing hydrogel systems.54
3.2 Enzyme catalyzed bond breakage
One of the most visible cell-responsive strategies in tissue
engineering has been enzyme catalyzed lysis of bonds. In
such a strategy, specific peptide sequences, or enzymatically
cleavable bonds (e.g. phosphates, esters) are engineered
into the hydrogel network or into hydrogel precursors. These
systems are fairly stable in the absence of enzyme activity,
but readily degraded, or activated, in the presence of a cell
secreting the correct enzyme. Various enzymes including
MMPs, elastase, alkaline phosphatase (ALP), esterases, thrombin,
plasmin, and cathepsin K have already been utilized to create
functionally responsive hydrogels.55 One will notice an absence of
enzyme catalyzed bond formation in this area of responsive
hydrogels.
3.3 Dynamic covalent chemistry
Dynamic covalent chemistry (DCvC)56 has played a significant
role in the current trend towards dynamic hydrogels. Some-
times classified as covalent adaptable networks, hydrogels
based on DCvC are characterized by the breaking and reform-
ing of covalent bonds based on their equilibrium (Keq) and rate
constants (koff and kon). These networks generally maintain the
number of linkages or crosslinks based on the Keq value, and
the time of the bond is generally governed by koff.
57 Several
DCvC systems are biocompatible and have already been used
to form hydrogels, including boronic acids,58 thioesters,59
hydrazones,60,61 imines,62,63 and disulfides.64,65 However,
hydrazone/imine and disulfide systems have recently come to
the forefront of use. Hydrazones remain dynamic under phy-
siologic conditions, imines become more dynamic with drops
in pH, while disulfides are responsive to local changes in
sulfide concentration or reductive power of the environment.
Most DCvC systems are tunable via physical organic chemistry
principles, and the adaptation of existing systems for use under
physiologic conditions remains an active area of research.
Fig. 2 Chemical strategies commonly utilized for cell-responsive hydrogels. (a) pH (redox) sensitive units (orange) can change protonation (oxidation)
state, often becoming charged (blue positive charges), leading to changes in binding constants or the osmotic pressure within the hydrogel; e.g. amine or
acid protonation, disulphide reduction (b) enzyme (yellow) catalyzed irreversible bond breakage of specific peptide sites (purple) in the hydrogel network
(or precursor); e.g. MMP specific cleavage, enzymatic cleavage of supramolecular hydrogelator precursor (c) dynamic covalent chemistry whereby two
units (green and pink) can dynamically, and reversibly, form covalent bonds depending on their reaction rates k1 and k2 and equilibrium constant (Keq); e.g.
hydrazone exchange/hydrolysis and disulphide formation, (d) supramolecular chemistry shown as the reversible binding and unbinding of a red ball and a
green cup based on the binding constants kon, koff, and equilibrium (Keq); e.g. polymer aggregation, host–guest interactions, H-bonding units, and
protein-small molecule binding, and (e) protein/DNA engineering as shown by two engineered biomolecules in the network (light green and purple)
reversibly bind and undergo conformational changes in response to the presence of a signal (yellow); e.g. incorporation of shape changing proteins
(calmodulin, adenylate kinase) and RNA aptamer binding.
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3.4 Supramolecular
Supramolecular assemblies and non-covalent interactions have
also been a rich source for the creation of dynamic and
responsive biomaterials.26 Nature, itself, relies heavily on the
use of supramolecular assemblies. In a truly biomimetic fash-
ion, the engineering of hydrogels designed from specific,
directional, tunable, and reversible non-covalent interactions
have enabled the creation of modular platforms with tunable
physical, chemical, and biological information.66,67 Supra-
molecular hydrogels68 owe their properties to the binding,
association, or assembly of discrete units. The assbembly of
these units is again governed by an equilibrium constant (Keq),
which is simply a ratio of association (ka) and disassociation
(kd) kinetics. Numerous supramolecular systems are capable
of creating hydrogels including host/guest interactions,69,70
directional hydrogen bonding,71,72 peptide amphiphiles,73–75
metal–ligand coordination,76 and small molecule gelators.77 In
theory, such systems built on weak and non-covalent inter-
actions are well situated to quickly respond to changes in the
environment or secreted factors. Although prolific as materials to
drive tissue formation,75 supramolecular materials are currently
under-represented in the area of cell-responsive hydrogel systems.
Progress in rational design, characterization, and control over the
sometimes sensitive supramolecular interactions remain both a
hurdle, and a promising research area.
3.5 Protein/DNA engineering
When creating bioresponsive systems, utilizing nature’s own
building blocks is a pragmatic approach. Numerous responsive
enzymes and protein/protein complexes are known, expressible,
modifiable, and purifiable from recombinant protein expression.
Integrating such functional or responsive protein units within the
network of a hydrogel allows a biosynthetic hybrid approach
to materials that can sense, respond, and influence cellular
behavior.78–80 In addition, DNA origami and DNA aptamer
technologies allow for the formation of spatially controlled
materials and high specificity to the binding of specific
analytes.81,82 While such biohybrid approaches are less scalable
and more expensive for the production of hydrogels, their
specificity and fine control can justify the high cost.
4. Enzyme responsive systems
Extensive research has developed enzyme-responsive hydrogels
for applications in drug delivery,83,84 imaging,85 diagnostics,86
tissue engineering,87 and regenerative medicine.21 The design of
enzyme-responsive hydrogels that enable cell and/or tissue specific
responses is currently based on two types of mechanisms:
(1) hydrogel networks with enzyme cleavable crosslinks or tethers;
(2) supramolecular assemblies generated from enzymatic conver-
sion of a non-self-assembling precursor. These mechanisms
mimic the breakdown and the formation, respectively, of ECM;
however, enzymatically based systems to regulate both have not
yet been developed.
4.1 Proteolytically-degradable hydrogels
Proteolytic sensitive hydrogels, engineered with enzyme sensi-
tive crosslinks of customized peptide sequences, directly enable
modulation of hydrogel degradation based on cell-secreted
enzymes (shown schematically in Fig. 3a). When compared to
their static and non-degradable counterparts, cells can spread,
migrate, and proliferate more freely within these protease sensi-
tive hydrogels.88,89 Cellular infiltration, vascularization, tissue
remodeling, and enhanced differentiation capacity of stem cells
have all been observed in these biomimetic hydrogel systems.
One of the earliest works to utilize enzymatically degradable
gels, from the 1980s, was based on crosslinked poly(2-hydroxyethyl-
L-glutamine) (PHEG, a poly(a-amino acid)). This hydrogel showed
significant degradation during post-implantation inflammatory
response, which was attributed to the presence of proteolytic
enzymes.90 Spurred from such initial studies, the field of
Fig. 3 (a) Water soluble polymers (blue) containing activated double
bonds can be crosslinked with thiol terminated peptide sequences (purple)
to form enzyme degradable hydrogels. A cell can remodel and migrate
through these hydrogel networks via proteolytic enzymes (yellow) cutting
covalently attached peptides (purple) within the network. (b) Polymer chains
(e.g. multi-arm PEG) are commonly functionalized with (meth)acrylates,
norbornene, vinyl sulfone, and maleimides. Advantages of MMP-degradable
hydrogels are shown in (c) rat calvarial defects 4 weeks after implantation
bone formation was observed within gels, which were (A) not susceptible
to MMP degradation, (B) with moderate degradation by MMP, and (C) highly
susceptible to MMP degradation. Assessed by radiography (left) and histology
(right), gels with highly degradable MMP networks showed significantly
higher bone formation than gels with less or no MMP-sensitive sites due
to cellular infiltration and remodelling. (d) MMP-cleavable starPEG–heparin
hydrogels provides a platform for extensive in vitro studies of heterocellular
cell–cell interactions between endothelial cells and mural cells (left), as well
as heterotypic cell–cell contacts via a tumor angiogenesis model (right).
(c) was reprinted from ref. 99. Copyright (2003) National Academy of Sciences.
(d) was reproduced with permission.103 Nature Publishing Group 2014.
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proteolytically-degradable hydrogels has become widely studied
in the context of cell-responsive biomaterials, as shown by
several thorough reviews specifically on this topic.91–93
More recent approaches have relied heavily on the use of
cross-links sensitive to MMPs, a large family of proteases which
effect natural breakdown of the ECM during processes such
as tissue resorption and remodeling.94 Although there is often
overlap between MMPs and their substrates, MMPs can show
substrate specificity,95 and the rate of degradation between
MMP cleavable sites can vary significantly.96 Depending on
the application in sight, careful choice of peptide substrates
can be matched with enzymes present in targeted sites, events,
or cell types.
Pioneering this approach of MMP degradable gels for tissue
engineering was a 4-arm poly(ethylene glycol) (PEG) system
with terminal vinyl sulfones to enable Michael-type additions
for functionalization with cysteine containing biomolecules.
By crosslinking the system with MMP cleavable peptides, and
functionalization with thiol-containing adhesive RGD sequences,
hydrogels were created where cells could attach, degrade,
and migrate through.97 By incorporating growth factors like
vascularization endothelial growth factor (VEGF) or bone morpho-
genic protein (BMP-2), these systems showed tissue formation
with vascularization98 and bone regeneration,99 respectively, in
in vivo models, non-degradable crosslinked hydrogels were free
of cellular infiltration (Fig. 3c). The modularity and tailorability
of this straightforward PEG–vinylsulfone system has effected the
creation of highly customizable cell culture environments. For
example, recently a stiffness-switching hydrogel was designed to
replace Matrigel in intestinal organoid expansion100—a previous
bottleneck for organoid technologies. Of note, the most success-
ful hydrogel was not the enzyme-responsive gel tested (collagen I
sequence); a hydrolyzable ester linkage with slowed degradation
provided the relevant timescale for this specific application.
Due to the synthetic accessibility of alkenes and the common
presence of thiols in biomacromolecules, thiol–ene reactions
like the Michael addition and photo-activated thiol–ene, are
natural choices for hydrogel formation with biomolecules. Some
of the commonly used alkenes for Michael addition and photo-
initiated thiol–ene to form hydrogels in a biological environment
are presented in Fig. 3b. It should be noted that methacrylates
can undergo Michael addition under appropriate conditions, yet
these conditions are usually not cell compatible.101
PEG–maleimide has shown some significant improvements in
crosslinking speed and efficiency over other systems (including
vinyl sulfone).102 Multi-component PEG–maleimide hydrogels con-
taining RGD, MMP degradable crosslinks, VEGF, and hepatocyte
growth factor (HGF), have been shown to increase angiogenesis in a
rat infarcted myocardium.37 Furthermore, injectable microgels
based on a similar architecture have shown increased vasculariza-
tion in the dorsum of mice.38 Microgel slurries have emerged
as a convenient work-around to the lack of injectability for
covalently crosslinked hydrogels.
Michael-type MMP cleavable hydrogels have also proven utility
as a laboratory platform to study tissue formation and the
study of cell–cell interactions. For example, a MMP-cleavable
biohybrid starPEG/heparin hydrogel system has been opti-
mized to support the morphogenesis of endothelial cells.103
Due to its susceptibility for remodelling, the hydrogel platform
enabled in vitro studies of heterocellular cell–cell interactions
between endothelial cells and other cells (Fig. 3d: left), as well
as heterotypic cell–cell contacts using a tumor angiogenesis
model (Fig. 3d: right).
Michael-type additions typically require a slightly alkaline
pH to occur (pKa of the Michael donor), which precludes the
use of some base sensitive molecules.104 Photo-initiated thiol–
ene conjugations can overcome this limitation. Photo-initiated
thiol–ene occurs quickly and in high yield at neutral pH, which can
be beneficial for in situ gelation. Furthermore, spatio-temporal
control (via light) of the biomolecule conjugation and gelation has
resulted in several novel materials applications in biofabrication.
Recent advances include complex patterns within hydrogels105–107
and the development of photo-crosslinkable thiol–ene hyaluronic
acid108 and polyglycidol109 based bioinks for 3D printing of cell–
hydrogel mixtures.
An excellent example of photo-initiated thiol–ene formation is the
thiol–norbornene photopolymerizable 4-arm PEG hydrogels, cross-
linked with an MMP degradable sequence (KCGPQGkIWGQCK).110
When human mesenchymal stem cells (hMSCs) were encapsulated
in such hydrogels, significant increases in cell spreading were
observed. Furthermore the osteogenic, adipogenic, and chondro-
genic differentiation capacity of hMSCs increased with increasing
MMP-degradability of the networks, showing a clear link between
differentiation capacity and the ability of a cell to remodel the
synthetic ECM.
Not only for degradation, enzymes can also be used to trigger
localized release through tethering of active molecules on the
crosslinker. For example, norbornene-functionalized PEG hydro-
gels were photo-crosslinked with MMP releasable pro-angiogenic
sequences. In this design, pro-angiogenic peptides (SPARC113
and SPARC118) were end-capped with IPESkLRAG sequences,
which are sensitive to MMP cleavage. These hydrogels success-
fully promoted angiogenesis when injected subcutaneously in
mice in an entirely degradation dependent manner.111 However,
compared to other pro-angiogenic protein delivery hydrogel
systems, the release profile of these enzyme degradable systems
were much shorter and would still need further optimization.
Applying such strategies to synthetically-modified naturally-
derived polymers, MMP-cleavable hyaluronic acid (HA) hydro-
gels that shut-down or allowed cell mediated remodeling have
also been created. By functionalizing HA with both maleimides
and methacrylates, thiol–ene crosslinking via an MMP-cleavable
peptide (GCRDVPMSkMRGGDRCG) could (or could not) be
followed by a secondary non-degradable photo-initiated cross-
linking of the methacrylates.112 In these hydrogels, osteogenic/
adipogenic differentiation of hMSCs was observed to be directed
mainly by degradation-mediated cellular traction. Permissive
(remodelable, without secondary crosslinking) matrices gave
rise to osteogenesis, while non-permissive (non-remodelable,
with secondary crosslinking) matrices led to adipogenesis.
Interestingly, when a stem cell’s environment was switched from
permissive to non-permissive via delayed secondary crosslinking,
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the cell also switched from an osteogenic to adipogenic phenotype.
The osteogenic cell morphology remained, yet an adipogenic
phenotype dominated. Recently, this same group utilized the
efficiency of thiol–ene photochemistry to print fibroblast-laden
HA modified with norbornene groups.108 To highlight the versa-
tility of the 3D printing technique, they created complex hydrogel
structures comprising of MMP-degradable and non-degradable
regions, and observed cell spreading throughout the printed
hydrogel when a degradable linker was used.
Moving towards complexity and autonomous systems, the
versatility of MMP-cleavable hydrogels has been shown in the
rational design of a negative feedback loop to inhibit MMP
activity.113 By loading an MMP cleavable hydrogel network with
a physically-associated MMP inhibitor (TIMP-3), hydrogels were
designed to buffer the local MMP activity. A significant decrease
in MMP activity was observed after delivery of these injectable
hydrogels to an infarcted myocardium (MMP overexpressed
region) in a pig model. Controlled delivery of MMP inhibitors is
always a challenge, due to dose limiting side effects; however, this
hydrogel system is a significant example of how cell-responsive
hydrogel systems can be designed for feedback loops to auton-
omously control pathological levels of enzyme expression.
MMP is not the only enzyme trigger used for hydrogels in
tissue engineering and regenerative medicine. Hydrogels cross-
linked with cathepsin K sensitive peptide sequences have been
shown to specifically degrade in the presence of osteoclasts,114
while elastase sensitive Ala–Ala repeat segments incorporated
in PEG hydrogels have been shown to allow both in vivo
degradation and cellular infiltration in mice115 and controlled
protein delivery.116,117 Thrombin, a key enzyme of blood
coagulation cascade, has been used to trigger anti-coagulant
release to prevent clotting. A modular feedback-loop PEG hydro-
gel system with thrombin sensitive peptide sequences has been
developed to prevent clotting through the release heparin on
demand,118 or respond to and reverse clot formation via
the release of tissue plasminogen activator.119 Both of these
thrombin mediated hydrogels have been shown to successfully
suppress critical points in the blood coagulation cascade.
The highlighted examples throughout this section only
represent some of the more commonly used enzymes and some
examples of their complimentary peptide. More exhaustive lists
of enzymes/peptides can be found elsewhere.36,91,95,96,120
4.2 Enzymatic assembly of nanostructures
Enzymes can not only be used to breakdown hydrogels, but also
to induce hydrogel formation via self-assembly of low-molecular
weight hydrogelators. This enzymatically triggered build-up of
fibrous nanostructures can mimic the enzymatic remodeling
and production of the ECM. The enzyme triggered dynamic
assembly, and in the future disassembly, is potentially a
promising strategy to mimic the behavior of natural fibers in
the cellular environment.
Most enzyme responsive supramolecular hydrogelators are
peptide based and are converted from an inactive (non-self-
assembling) to an active (self-assembling) form via hydrolysis
or condensation of peptide precursors (Fig. 4a).77 Generally, a
Fig. 4 (a) General schematic of an enzyme-triggered self-assembly mechanism. Peptide based precursors (shaded green units) are equipped with a tail
(blue), that prevents self-assembly. Upon specific enzyme (yellow) cleavage, the tail is removed and the active hydrogelator is formed, assembling into a
fibrous network (right). Often these hydrogelators can self-assemble into several nanostructures. (b) A Nap-C(O)-FF based unit possesses all of the
characteristic design elements. A self-assembling peptide with a hydrophobic moiety (naphthalene) to drive self-assembly and a dipeptide unit (Phe–Phe)
as acceptor/donor of hydrogen bonds, an enzyme cleavable bond (esteraste, ester), that can remove a self-assembly inhibitor (deprotonated carboxylic
acid).121 (c) Self-assembly of a cyano-6-aminobenzothazole (CBT) based precursor 1 into nanofiber 2 was catalyzed by extracellular ALP removal of a
phosphate that prevented self-assembly. After cellular uptake of nanofiber 2, reduction of a protected thiol by glutathione (GSH) in the intracellular
environment leads to intermolecular disulfide formation (hydrogelator 2) and the formation of the second nanofiber (2D). (c) was reprinted with
permission.126 Copyright (2016) American Chemical Society.
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known self-assembling unit is conjugated to an enzymatically
labile group that inhibits self-assembly. Upon cleavage of this
inhibitor, hydrogelators then freely self-assemble to form
nanostructures, mainly via hydrophobic interactions, hydrogen
bonding, electrostatics, and p–p interactions. Through design
of the peptide sequences and dictation of the self-assembly
pathways, the morphology of the self-assembled structures can
be controlled and used to direct cellular behavior.30 A majority
of the work reported to-date on enzymatically triggered hydro-
gelation has not yet been applied to tissue regeneration, but has
focused on cell death and entrapment for cancer therapy.77
Despite this, these systems carry interesting design principles,
and their application towards tissue regeneration is overdue.
An illustrative example of enzyme triggered nanostucture
assembly can be seen in systems based off naphtyl–Phe–Phe
self-assembling units. Towards creating enzyme sensitive self-
assembling units, a monomer (shown in Fig. 4b) was designed
with three functional parts: a dipeptide capable of forming
a hydrogen-bonding motif, a napthyl group to provide a hydro-
phobic driving-force to self-assembly, and an enzymatically
cleavable pendant ester of butyric diacid, which provides
electrostatic repulsion to prevent self-assembly.121 Upon expo-
sure to esterases within HeLa cells, the anionic butyric acid is
removed, and the resultant hydrogelators self-assemble to form
intracellular nanofibers, leading to cell death.
Other self-assembling systems have also been created with
specific MMP cleavable tails. A peptide–lipid conjugate precursor
(palmitoyl-GGGHGPLGLARK-CONH2) has been successfully
designed with an MMP-7 cleavage site that removed a highly
charged Arg-Lys sequence. The supramolecular hydrogelator
self-assembles intracellularly into nanofibers upon enzymatic
cleavage, leading to death of cancer cells.122 Importantly, this
supramolecular system showed high cytotoxicity to five different
cancer lines (HeLa, MIAPaCaII, SKBR3, MCF-7, A431), yet low
cytotoxicity to normal cells (microvascular endothelial cells and
pancreatic epithelial cells), even in co-culture situations.
Recently, the ability of enzyme to induce self-assembly to
enable both cell and organelle specific targeting was shown by
conjugating triphenyl phosphinium (TPP), a redox modulator
capable of targeting cancer mitochondria, to an enzyme inducible
tetra-peptide precursor capped with a fluorophore (4-nitro-2,1,3-
benzoxadiazole, NBD).123 The tetra-peptide precursor, ((NBD)-
FFYpK(TTP)) undergoes dephosphorylation selectively in the
environment of cancer cells (upregulated ectophosphatases).
The conjugate then self-assembles, is endocytosed by cancer
cells, escapes from lysosomes, and the TPP specifically targets
the mitochondria.
Enzyme responsive self-assembling systems have also been
employed to image local enzymatic activity. Direct attachment
of fluorophores to enzymatically self-assembling systems85
and co-assembly strategies124 have allowed the imaging of
organelles within cells and enhanced theranostic treatments,
respectively. Imaging of fluorescent nanostructures in breast
cancer cells (MDA-MB-468) has even been shown via a bond-
breaking bond-forming condensation to create a fluorescent
monomer upon enzymatic cleavage (among other stimuli).125
In an advanced enzyme-responsive self-assembly system,
Liang and co-workers designed a small-molecule hydrogelator
that can change its self-assembled nanostructure, depending
on the cellular environment (Fig. 4c).126 In the extracellular
matrix, the 2-cyano-6-aminobenzothazole (CBT)-based precursor
(C(SEt)EY(H2PO3)FFG-CBT) undergoes dephosphorylation, in
response to ALP, forming a hydrogelator that self-assembled
into nanofibers in the extracellular environment. The fibers
underwent endocytosis where intracellular glutathiones (GSH)
reduce the disulfide bonds of the protected cysteine residue
(Cys(SEt)), allowing intermolecular cyclic dimers of the hydro-
gelator to form. This new molecular structure led to the formation
of a different morphology of nanofibers. The environmentally
specific self-assembly was validated through in vitro studies with
HeLa cells and characterization of the structures and compounds
formed extra- and intracellularly when ALP or GSH was intro-
duced; however, the effects of this differential self-assembly
system on the cells has not yet been fully reported.
While the majority of research on self-assembling structures
have focused on homochiral molecules, in particular L-amino
acids, there has also been increasing efforts to use D-amino acids
and mixtures.127 In the molecular design of enzyme responsive
supramolecular hydrogelators, simple changes in chirality can
control the interactions of the self-assembled system with target
cells. For example, molecules with more D-amino acid substitution
were found to be more toxic than their corresponding enantiomer
potentially due to their resistance towards proteolysis.128 The
accumulation of nanoscale networks in the pericellular space
hindered regular cellular activities, such as migration and
adhesion, and led to cell apoptosis. Based on these findings,
nanoscale hydrogel networks have been developed as inhibitors
of cancer cells;129 however, inhibition of migration and adhesion
can also be effectively used to control tissue formation. In future
designs of chiral self-assembling structures for biomaterials, it is
clear that the chirality of each amino acid is essential to control
the morphology, degradation, and cell signaling behavior of the
resultant nanostructures.130
4.3 Prospects
Several other enzyme responsive systems present concepts that
hold potential for future design of biomaterials. For example,
Roberts et al. have developed a dynamic PEG-grafted surface
with elastase sensitive dialanine protected RGD peptides.131 The
protected-RGD surfaces were shown to have lower, while the
elastase deprotected-RGD surface had higher amounts of cell
spreading and adhesion. Therefore, when MSCs were cultured
on these surfaces, they showed a change from a growth state
(low adhesion) to a differentiating state (high adhesion) upon
elastase addition. Although this system was not shown to be cell-
responsive (exogenous delivery of elastase), the use of enzyme
triggers to control the phenotype of progenitor cells paves the
way to develop cell culture environments that can control
phenotypic changes in cells and tissue formation.
In living systems, enzymatic processes are often part of a
feedback network. Mimicking such feedback loops, a hydrogel
system with both enzymatically cleavable crosslinks and
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hydrolytically activated crosslinks (thioester/maleimide) has
been designed.132 In-depth studies on the reaction kinetics have
led to fine control of gel transitions (gel–gel or gel–liquid–gel)
based on time and enzyme concentration. The incorporation of
such a design in the development of hydrogels will allow progress
towards more complex materials, which have pre-programmable
responses to environmental biochemical triggers.
Despite advances in using enzymes to create cell-responsive
hydrogel systems, there are some limitations. A noticeable draw-
back is the current lack of reversibility. Hydrogel degradation,
self-assembly, or phase changes are currently a one-way street,
limiting some applications that may benefit from more reversible,
controllable, and long-lasting systems. Studies, such as the
enzymatically cleavable and hydrolytically activated crosslinking
system (vide supra), show clues to the utility and behavior of
systems that both degrade and rebuild; however, currently these
two phenomena are triggered with different mechanisms.
While enzymes are famous as highly selective catalysts, most
of the cleavable peptide sequences incorporated in these hydro-
gels are degradable by more than one type of protease. In
addition, limited studies have been conducted to tease out the
changing biophysical properties of enzyme degradable hydro-
gels, which play an important role in stem cell fate.39,40 There is
little control over the homogeneity of these hydrogels when
cells are encapsulated, making the physical characteristics of
the networks difficult to predict or measure. These systems
have seen utility and good proof-of-concept in well-controlled
environments, yet testing in more complex in vivo systems is their
next hurdle, especially with respect to self-assembling systems.
Studies of in vivo implantation of enzyme-responsive hydrogels
has shown promising cellular infiltration,99 vascularization,37,133
and neobone formation in bone defects,99,134 yet efficient transla-
tion towards clinically relevant tissue regeneration requires more
work in terms of upscaling, large animal model proofs, and
clinical trial feasibility.
5. Mechanically responsive systems
One of the emerging areas of cell–biomaterial interactions is
the interplay between the mechanical properties of a material
and the mechanosensing framework of a cell. Mechanobiology
is quickly becoming an active field,135 and mechanically
instructive and responsive biomaterials are advancing in a
concerted fashion. In the past decade, it has become a central
pillar of biomaterials that a hydrogel’s stiffness can directly
influence cellular behavior136 and affect the differentiation of
stem cells into different lineages.39,137 At the most basic level,
neuronal cells perform best in soft matrices, while osteoblasts
perform best in hard matrices; the differentiation of progeni-
tors is most efficient in a matrix with elasticity comparable to
the mature cell’s natural niche.
Natural ECM components exhibit non-linear rheological
properties including strain-stiffening,138 stress-relaxation and
viscoelasticity,139 due largely to non-covalent and reversible
interactions, allowing for the matrix to respond to the presence
of mechanical forces from cellular adhesion. Such materials dis-
play frequency (time) and magnitude (force) dependent relation-
ships between the storage (G0) and loss (G00) moduli of the
materials. Efforts to mimic these behaviors in synthetic systems
are uncovering elements of rational design of such properties.
Nicely compared, the differences in mechanical properties of
peptide based natural and synthetic hydrogels have been topics
of a comprehensive review.140 In general, mechanically responsive
networks have the potential to display different mechanical infor-
mation over time, in response to force, and even allow disruption
and reformation of bonds during cell and tissue ingrowth.
5.1 Strain-stiffening
Strain-stiffening is a common feature of natural physically
associating hydrogels,141 allowing for cellular traction and
communication even in very soft matrices.142 Unfortunately,
biomimetic strain stiffening has been difficult to engineer in
synthetic hydrogels. A breakthrough in this area was introduced
in 2013 with ethylene glycol functionalized poly(isocyanides)
(PICs, Fig. 5a) that were able to recreate the magnitude and
response of many ECM strain-stiffening properties. Akin to
collagen bundling, this biomimicry was experimentally attributed
to the supramolecular bundling of the PIC polymers into a
nanofibrous network.143,144 The synthetic modularity of the
system allowed engineering of the mechanical properties, includ-
ing the critical stress point (the strain at which the hydrogels
exhibit stiffening).145
Control over the differentiation of 3D encapsulated stem
cells was shown via changes in the strain stiffening behavior
of the biomimetic PIC hydrogels.41 Within a series of soft
(0.2–0.4 kPa) PIC gels, moving the critical stress point from 8 Pa to
20 Pa induced a switch in hMSC differentiation from adipogenesis
to osteogenesis (cultured in a 1 : 1 osteogenic:adipogenic culture
medium). These gels all exhibit similar elasticity at rest, yet when
the cells exert mechanical force on the adhesion sites (covalently
attached GRGDS), the materials respond differently. To further
advance this study, the authors were able to find a correlation
between DCAMKL1 expression (a microtubule-associated protein)
and the onset of the strain stiffening. This observation supported
DCAMKL1/RUNX2 as a potentially important mechanotransduc-
tion switch in these 3D strain-stiffening matrices.
More recently, a self-assembly, covalent fixation, and covalent
crosslinking strategy to design strain-stiffening hydrogels was
introduced.146 Utilizing bis-urea bola-amphiphiles with internal
acetylenes, covalent fixing of the self-assembled flexible fibers,
followed by azide–alkyne crosslinking, led to strain stiffening
hydrogels. Pre- and post-crosslinking both showed bundled fibers,
and control of concentration led to control of stiffening onset.
These observations give promising insights in the rational design of
biomimetic strain-stiffening materials. Cell-based studies with the
bis-urea materials have not been performed, yet will prove difficult
due to their non-transparent nature (poly(acetylene) backbone).
5.2 Viscoelasticity
Viscoelastic materials exhibit both elastic and viscous proper-
ties that vary with the timescale of the deformation applied.
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Many of the natural ECM components used for cell culture
are viscoelastic and stress-relaxing (e.g. collagen, basement
membrane, fibrin). This plasticity of the matrix allows for
cellular remodeling of the material via cellular forces139 (combi-
nation with enzymatic degradation). In attempts to recapitulate
this dynamic nature, many of the synthetic systems rely on
reversible and/or non-covalent interactions that have inherent
timescales.25,27,29
The importance of viscosity on cell behavior was first
observed within a series of 2D poly(acrylamide) hydrogels. An
increase in the hydrogel’s viscous behavior led to enhanced
hMSCs differentiation potential to a number of lineages.147
Later, in 3D alginate hydrogels, significant differences in cell
spreading and focal adhesion formation were shown between
elastic and viscoelastic 3D alginate hydrogels (covalent vs. ionic
crosslinking) at a similar initial modulus.148
Recently it has been shown that the relaxation rate of visco-
elastic hydrogels can directly influence MSC differentiation.149
Utilizing a series of alginate hydrogels, from high molecular
weight to low molecular weight with grafted PEG, stress relaxation
of the gel was tuned independently of the stiffness, degradation,
and adhesive ligand density (relaxation constants = 3300–70 s).
Gels with a rapid rate of stress relaxation (low molecular weight
alginate with grafted PEG) led to significantly higher proliferation,
spreading, and osteogenic differentiation than gels with a low rate
of stress relaxation (high molecular weight alginate). Clusters of
adhesive ligands in the vicinity of cells were observed to a larger
extent in the rapidly relaxing matrix; the force associated with this
integrin-ligand clustering was previously shown to effect osteo-
genic differentation.40 The rapidly relaxing alginate gel (B1 min)
was the only matrix that allowed osteogenic differentiation and
the formation of an interconnected, mineralized, and collagen I
rich matrix—hallmarks of bone formation.
Viscoelasticity, and stress-relaxation, can also be engineered
into hydrogels utilizing well-defined and reversible crosslinks
within the material. While many dynamic covalent chemistries
(DCvC) are triggered by external factors, such as pH, light, and
temperature, the hydrazone exchange reaction maintains a
dynamic equilibrium under physiological conditions and lends
itself well to the formation of biomaterials. In an instructive
example, Anseth and co-workers have developed a multi-arm
PEG based hydrogel that is crosslinked via DCvC between
hydrazones and aldehydes (Fig. 5b).60 By tuning the nature of
the aldehyde (aliphatic and aromatic) and the topology of the
Fig. 5 Significant examples of hydrogels able to respond to the mechanical forces of a cell. (a) Strain-stiffening hydrogels, create a stiffer network
(orange) upon applied strain from a cell, via its integrins (light blue hook), during the generation of traction forces. Poly(isocyanide) (PIC, structure shown)
gels, allow for recapitulation of the strain-stiffening environment of the ECM. PIC gels showed stress stiffening behavior within the biologically relevant
stress regime (see graph) in comparison to other hydrogel systems.41 G0 represents the equilibrium bulk stiffness and sc is the critical stress for the onset
of stress stiffening of the polymer gel. The effect of varying these parameters through e.g. alteration in polymer chain length showed the ability to switch
stem cell differentiation. (b) Viscoelasticity, as in dynamic covalent hydrazone based hydrogels, allows for facile cellular remodeling of the gel. Shown
both schematically (above) and chemically (middle), these dynamically interchangeable bonds create materials with different mechanical information on
different time scales, and greatly affects the ability of cells to grow protrusions into the material. The dynamism of the aliphatic vs aryl aldehyde on cell
viability was studied via C2C12 myoblasts encapsulated in 8-H:(80% 8-AA,20% 8-BA) (comprised of 80% aliphatic aldehyde and 20% aryl aldehyde)
showed actin filaments and extend lamellipodia and filopodia, while cells encapsulated in 8-H:8-BA (100% aryl aldehyde) remained round (bottom).60
(c) Sliding hydrogels based on poly(rotaxanes) provide permanent, yet mobile crosslinks (above). Shown with a-cyclodextrin threaded PEG hydrogels
(middle), this atypical architecture allows for the clustering of adhesive ligands and the remodeling of the network via forces from the cell. Again here,
authors see enhanced propensity for differentiation in such dynamic hydrogel architectures. hMSCs in sliding hydrogels allowed formation of protrusions
(bottom), which was attributed to their ability to rearrange crosslinks and ligands.160 (a) was reproduced by permission from Macmillan Punishers
Ltd: Nature41 copyright year 2015. (b) was reproduced with permission60 John Wiley and Sons 2013. (c) was reproduced with permission.160 John Wiley
and Sons 2016.
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gel (4-arm and 8-arm PEG), they report the ability to cover a
wide range of elastic moduli (1.8–27 kPa) and relaxation time
constants (10 s–approximately hours). Within this series of
dynamic gels, C2C12 myoblasts were found to fuse and demon-
strate myotube-like morphology only in the dynamic hydrogels
(relaxation constant 91 s) (Fig. 5b). In the more static hydrogels
(slower hydrazone exchange), the cells kept mostly a rounded
morphology. Less than 30% of the cells grew external protru-
sions into the material after 10 days of culture.
Materials made from such well-defined chemical strategies
can be optimized, correlated to, and rationally designed based
on solution phase kinetics and equilibrium constants.150
Furthermore, these dynamic materials have the ability to
maintain a constant bulk behavior, while responding acutely
to the local forces from a cell. Owing to the constant bulk
properties, these hydrazone–PEG hydrogels have also enabled
the recording and analysis of neurite outgrowth from embroyid
bodies to be translated into cellular forces involved in the
remodeling of the viscoelastic material.151 Furthermore, recent
results show that a hydrogel system based on the reversible
hydrazone linkages was able to promote neural progenitor growth
and have a marked increase in neural development in zebrafish
when compared to a traditional alginate hydrogel.62
Numerous non-covalent and supramolecular hydrogels are
capable of displaying viscoelastic behavior.70,71,152–155 However,
there are no known studies linking this viscoelasticity to cellular
behavior. Cellular adhesion to supramolecular surfaces156,157
and supramolecular fibers75 has been well demonstrated, yet
the correlation to viscoelasticity or timescale remains to be
reported. The effect of viscoelasticity within self-assembled
supramolecular matrices on 3D cell culture remains an open
research question and will become crucial in upcoming designs
of a fibrous synthetic ECM.
5.3 Mechanically interlocked systems
The mechanical remodeling of a network can also be accom-
plished with permanent, yet mobile, crosslinks within a hydrogel.
Topologically interlocked networks like poly(rotaxanes)158 have
been extensively used in the toughening of materials due to their
dynamic and stress-responsive network architectures.159 Primed
for a foray into biomaterials, a poly(rotaxane) sliding hydrogel
with mobile crosslinks and adhesion ligands has recently been
reported (Fig. 5c).160 Based on an a-cyclodextrin threading PEG
polymers, these hydrogels not only have enhanced toughness,
but also the ability for cells to remodel the sliding crosslinks
and/or adhesive ligands. Key advancements were both the
ability to crosslink the poly(rotaxanes) in a cell-friendly manner
and prevention of cyclodextrin crystallization. As seen above,
MSCs showed increased ability for differentiation to a variety of
lineages in this remodelable gel, when compared to a similarly
constructed statically crosslinked hydrogel.
This initial study represents a promising area of research in
the future as there is a wealth of information on the unique
properties of topologically interlocked networks. One can quickly
imagine adding shuttling functions (e.g. in relation to transport
of oxygen and removal of cellular metabolite byproducts) and
off/on switches within these materials for enhanced control
over cellular behavior.
5.4 Mechanochemical bond
In the cell’s environment, there are several versions of mechani-
cally sensitive bonds that provide enhanced function and respon-
siveness in the presence of mechanical force.45,161 Frequently
termed ‘‘soft mechanochemistry,’’162 the mechanically responsive
bonds in biological systems are often based on protein conforma-
tion changes. In an ideal bond, the lifetime and/or strength of
the bond or interaction is constant regardless of the applied
force on the bond. However, recent research has shown that
many molecular interactions involved in cell adhesion and
movement deviate from this ideal relationship.163 Catch bonds
are capable of increasing in strength and lifetime under applied
force, while slip bonds decrease in persistence under force. An
excellent example of these phenomena exist in cadherins; the
presence of all three types of bonds allows for cadherins to
withstand tensile force and tune the mechanical properties of
adhesive junctions.164
Mechanochemistry within the realm of polymer chemistry
has seen resurgence in recent years. Traditionally, these systems
revolve around creating a chemical reaction (generally bond
breakage) under applied force; however, recently inspired by
molecular catch bonds, systems that strengthen with applied
force are also being currently developed.165 While these are
covalently based systems, there is some evidence that supra-
molecular based hydrogels can undergo force mediated modulation
of binding constants.166 In addition, mechanophore research
has recently allowed for the rational design of molecular
sensors for mechanical force.167,168 Currently, the mechano-
chemical systems developed have not been designed active on
the cellular level of force generation, and only a few verified
versions of synthetic catch bonds have been documented.169
Yet, rational design and benchmarking170 pave the way for
innovation. Creating systems that are mechanochemically
active to the forces of individual cells inherently will produce
fragile materials that can create extreme difficulties in hand-
ling. It is likely that such systems may need an in situ activation
step, or rely on reversible non-covalent interactions, to create
functional hydrogel biomaterials.
6. Metabolite and small molecule
responsive systems
While enzyme responsive hydrogels have proven utility for the
construction of cell-responsive materials, these protein-based
catalysts are not the only molecular stimuli in the environment
of a cell. In the cellular niche, there are numerous pH or
reductive changes, non-catalytic proteins and small molecule
metabolites, and dissolved gases that provide functions
ranging from structural support to inter-cellular signaling.
Creating synthetic systems that are capable of responding to
these highly varied metabolic products (or fuel) of a cell can
prove difficult, but can allow significant advancements in
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specificity, selectivity, and choice of triggers. Furthermore,
these strategies can allow for reversibility of response, since
many of these systems are based on binding or recognition
events.
Within this section, one will find common use of biohybrid
materials relying on synthetic integration of highly specific
and bioengineered proteins and nucleic acids. Although fully
synthetic materials are less prevalent, progress has been made
via dynamic recognition events e.g. boronic acid sensing of
glucose. Many of these metabolite/small molecule responsive
systems have not yet found applications in tissue engineering
or regenerative medicine; however, strategies able to respond to
metabolic states or differentiation events in tissue formation,
can start to be entertained.
6.1 pH and redox
Hydrogels that are sensitive to pH changes84 were among the
first classes of responsive hydrogels designed to change in
response to physiochemical factors,171 while redox systems have
traditionally been used intracellularly.84 Both systems respond to
local extra and intra-cellular environments and are popular with
drug-delivery strategies. Easily accessible chemical motifs can
impart pH and/or redox sensitivity; however, pH and redox
changes nearby a cell are generally neither large, nor specific.
For these reasons, pH and redox responsive systems are some-
times coupled with an enzyme for signal amplification
(i.e. glucose responsive hydrogels, vide infra).
There exist two main strategies to design hydrogel pH
responsive systems: the use of polymers with ionizable chemical
groups that undergo conformational or solubility changes, and
polymeric systems with acid-sensitive bonds. A major application of
pH sensitive hydrogels includes the sensing and response of hydro-
gel networks to the acidic environment (due to accelerated glycolysis)
around cancerous cells.50 Poly(acrylic acid) (PAA, anionic poly-
electrolyte) and poly(diethylaminoethyl methacrylate) (PDEAEMA,
cationic polyelectrolyte) are the most commonly studied polymers
with ionizable chemical groups, and can swell/deswell depending
on pH changes, often releasing a drug.14,172 As an example of
bond sensitivity to pH, Schiff base hydrogel systems, including
alginate–chitosan,173 and low-molecular weight hydrogelator
(LMWG) hydrogels,174,175 have found application in cancer
therapeutics and wound healing.63 Self-assembled hydrogelators
with doxorubicin (DOX) have been reported to form injectable
systems that effectively and selectively deliver DOX to breast
cancer in mice and significantly inhibit tumor growth.173,175
Moving towards redox-sensitive systems, disulfide cross-
linked hydrogels, prone to rapid cleavage by glutathione, have
recently been used in effective hydrogels for gene-therapy and
tissue engineering. Reduction sensitive self-assembled DNA
nanogels (held together by disulfide links between the DNA
building blocks) have been shown to disassemble within a cell,
and were capable of effectively delivering an anti-proliferation
gene.82 In addition, Varghese and co-workers designed a dis-
ulfide crosslinked PEG hydrogel that was shown to degrade in
the presence of multiple cells without external stimulus. They
observed that this degradation rate could be tuned in vitro via cell
type, encapsulated cells density, and disulfide cross-link density.
These PEG hydrogels were successfully used to deliver, and
increase retention of, hMSCs into mouse dorsal muscle.64 Various
other redox responsive systems have been employed for drug
delivery, but require the input of a user-defined stimulus.84,176
pH and redox sensitive hydrogels can also be combined into
one functional system. Poly(methacrylic acid) (PMMA) hydro-
gels of micrometer sized with dual pH and redox sensitivity
have been reported by Kharlampieva and co-workers.49 Again
targeting DOX delivery to cancerous cells, the pH sensitivity
facilitated DOX encapsulation, while the incorporation of dis-
ulfide crosslinks triggered rapid degradation of these hydrogels
in the reducing environment of a cell’s cytoplasm. The concept
of this system is represented in Fig. 6 where DOX (red spheres)
are encapsulated in the hydrogels at neutral pH and degraded
in the cytosolic space by gluthathione. The authors have shown
that these DOX containing mirco-hydrogels were capable of
90% cytotoxicity when incubated with HeLa cells for 48 h.49
Such dual responsiveness has also been effectively translated to
self-assembled cyclodextran/benzimidazole nanogels for con-
trolled release.177
A newer concept to design responsive hydrogels is to use a cell
or tissue’s generation of reactive oxygen species (ROS). These
species play important roles in cell signaling pathways and
abundantly exist at sites of inflammation and tissue healing.52
Several studies have been reported on 3D polymeric scaffolds,
crosslinked with oligo(proline) ROS cleavable sites. These
scaffolds showed enhanced degradation when incubated with
ROS generating macrophages, as well as improved host cell
infiltration and angiogenesis when implanted subcutaneously
in mice.178,179 This concept is transferrable to hydrogels for
a general degradation mechanism during tissue growth and
remodeling, while also providing a potential protective effect.
ROS protective hydrogels have been shown to protect both
pseudo-islets and hMSCs under high oxidative stress.180
Fig. 6 Many pH and redox responsive systems are engineered for drug
delivery across a cell membrane. Shown schematically are hydrogel
microspheres, loaded with a drug or growth factor (orange spheres), being
taken up by a cell and then releasing its cargo upon breakdown of
the hydrogel network. Poly(methacrylic acid) (PMAA) hydrogels with dis-
ulfide crosslinks and with dual pH and redox sensitivity have been success-
fully created for delivery of doxyrubicin to cancer cells. These hydrogels
swell at neutral pH and uptake DOX, degrade in cytosolic space due to
presence of gluthatione (GSH), which reduces disulfide bonds and release
DOX. Adapted with permission.49 Copyright (2015) American Chemical
Society.
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6.2 Molecule specific
Molecule specific hydrogels commonly rely on a biohybrid
approach. The specificity (and amplification) of biochemical
recognition, and the ability of this recognition to provide a
response, is difficult to recreate in fully synthetic systems.
However, it is this same specificity that empowers molecule
specific responsive systems greater potential in the complex
biological environment. Some of the best known and most
advanced molecule specific hydrogels have been created
towards the treatment and control of diabetes. Glucose respon-
sive and insulin releasing hydrogels hold promise to replace
simple insulin injection, and such hydrogel systems have been
one of the few to be approximated by fully synthetic systems.
Most hydrogels designed for glucose responsiveness, utilize
enzymatic conversion of glucose to gluconic acid, in presence of
glucose oxidase (GOx), to induce the swelling of pH responsive
hydrogels for insulin release (Fig. 7a).181 For example, glucose
responsive chitosan (protonatable amine) microgels have been
designed using this approach, and their glucose dependent
insulin release showed in vivo efficacy in controlling glucose
levels in diabetic mice.54 The production of H2O2 from GOx (by
oxidizing glucose) has also been utilized to engineer glucose
responsive hydrogels.182 Based on the sensitivity of ferrocene/
cyclodextrin complexation to oxidation, redox-sensitive hydro-
gels have been created from ferrocene terminated pluronic and a
polymer with cyclodextrin pendant groups. The hydrogels under-
went a gel–sol transition upon exposure to glucose solutions.
While the previous examples are effective, these systems lack
specificity to only glucose, due to the hydrogel response being
secondary in nature. In order to increase glucose specificity,
fully synthetic polymers containing phenyl boronic acid (PBA)
have gained much attention (Fig. 7a).58 Boronic acids are well
known to form dynamic covalent bonds with diols, especially
sugars, in aqueous media. Sakurai and co-workers were among
the first to use such a system, where the creation of a charged
PBA glucose complex swelled the hydrogel and allowed release
of insulin.183 More recently, work by the Anderson group has
created a series of self-healing, tunable, shear-thining, inject-
able, and glucose responsive hydrogels by incorporating both
the PBA and a competitive diol (hydrolyzed sugar) within the
polymer network.152,184 The glucose responsiveness (and insulin
or IgG release) of these hydrogels were shown with hyper-
glycemia mimicking conditions, and these hydrogels showed a
typical foreign body reaction upon implantation in mice, making
them promising candidates for insulin delivery applications.
As seen by the glucose–PBA based hydrogels, systems based on
the response to a binding event from a specific small molecule are
possible in many fashions. Relying on a urate responsive protein–
DNA complex, Weber and co-workers developed a hydrogel designed
to provide a protective environment in patients with gout.185 The
hydrogel system was based on a urate repressor protein (HucR),
conjugated to poly(acrylamide), and crosslinked via the addition of
oligomeric hucO DNA ([hucO]n). This system forms a crosslinking
HucRhucO complex that dissociates at elevated urate concentra-
tions, resulting in dissolution of the hydrogel. By incorporating urate
oxidase, the authors have shown that the hydrogel system responded
protectively to uric acid pulses in a mice model.186
An exciting approach to design molecule specific dynamic
hydrogels is by translating binding induced protein conformational
Fig. 7 Selected examples of molecule specific responsive hydrogels (a) phenyl boronic acid (PBA) hydrogels for insulin (purple spheres) delivery: PBA
specifically recognizes diols such as glucose. A charged PBA–glucose (G hexagons) complex is formed swelling the hydrogel network and releasing
insulin as a function of glucose concentration. Due to the dynamic nature of the PBA–glucose complex, such hydrogels are often quick to respond and
can be made injectable (shear-thinning).152 (b) Protein conformational changes (orange sections of hydrogel network) upon ligand binding can translate
nanoscale motion into macroscale motion or materials properties. For example, calmodulin (CAM) conjugated PEG hydrogels showed volume changes
upon binding to a trifluoroperazine (TFP) ligand.189 CAM goes from its extended shape (in the presence of calcium ions (left)) to a collapsed conformation
(right) upon binding to TFP ligand. (c) Adenylate kinase (another conformationally changing protein) hydrogels were made by crosslinking polyHPMA
(with maleimide side groups) with a thiolated mutant of adenylate kinase (AKtm). These hydrogels undergo macroscopic motion when exposed to ATP.
(d) DNA aptamer recognition for cell release: apatmers (purple) sensitive to ATP (orange) are initially hybridized to complementary strands (green) with
adhesive RGD attached (yellow), creating a cell-adhesive environment (top). Upon introduction of ATP (bottom, exogenous or cell-secreted), aptamers
release their complementary strand and bind to ATP, thus creating a non-adhesive environment.193 Aptamer–target interactions can be designed for
virtually any target, making this a highly promising, though costly, strategy. (c) was reprinted with permission.191 Copyright (2008) American Chemical
Society. (d) was adapted from ref. 193 under creative commons license (CC BY 3.0).
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changes into macroscopic motion or reorganization (Fig. 7b).
For example, calmodulin (CaM) is a protein with three distinct
shapes: unstructured, extended (in presence of Ca2+), and
collapsed (in the presence of phenothiazine anti-psychotics).
CaM was first successfully incorporated into star PEG hydrogels
that were shown to undergo a significant volume decrease (up
to 15%) upon binding of trifluoroperazine.187 Incorporating a
phenothiazine ligand into an acrylamide network containing
CaM allowed for a triple-state responsive gel system that
swelled and de-swelled as a function of calcium and phenothia-
zine concentrations.188 These hydrogels were shown to allow
active control of molecular transport across the gel and control
fluid flow from a microfluidic device. CaM based hydrogels
have even found application for tissue engineering via spatio-
temporal control of growth factors delivery. Murphy et al. have
designed growth-factor laden PEG–CaM–PEG acrylate based
hydrogel microspheres, using two-phase suspension polymer-
ization that showed a maximum volume change around 76%.
The authors have shown that temporal release of VEGF and
BMP-2 could be achieved by varying the timings of CaM’s
ligand trifluoperazine induced volume changes.189 CaM is just
one good example of molecular motion in protein engineering
for hydrogel design, as touched upon briefly in a recent
review.190 Notably, systems like adenylate kinase-ATP respon-
sive gels (as depicted in Fig. 7c) may see more application in the
future, as they respond to a more relevant cell metabolite
(adenosine triphosphate).191
Although the a priori engineering of target-responsive hydro-
gels remains difficult, directed evolution of DNA aptamers give
a strategy to create systems that respond to a desired target
molecule. Aptamer based hydrogels can be made responsive
to specific analytes, for example, an excess of adenosine and
thrombin.192 Taking this design principle further, Qu and
co-workers have recently created cell responsive hydrogels that
control 2D cellular adhesion in response to ATP concentration
(Fig. 7d). By conjugating ATP aptamers to an alginate hydrogel
and hybridizing with RGD functionalized complementary DNA,
a cell adhesive surface was formed. Exogenous delivery of ATP
was shown to cause dehybridization of the DNA, rendering
the surface non-adhesive and releasing cells. The system was
demonstrated to be highly selective to ATP and even responsive
to ATP signaling from cells in co-culture.193 Such a strategy
requires non-trivial aptamer generation, but can be applied to
a wide variety of targets and incorporated in a wide variety
of systems.
6.3 Gas sensitive
The responsiveness of hydrogels to and control of gaseous
metabolites is a significant need in 3D scaffolds for tissue
engineering. The difficulty in maintaining oxygen partial pres-
sures within tissue engineered constructs and in 3D cell culture
is well known, but is difficult to control or to quantify/image.
Ultimately, re-vascularization is desired to enable the long term
viability of an engineered tissue;194,195 however, biomaterials
that can sense and/or control the concentration of gaseous
metabolites remain highly sought after. Biomaterials capable of
delivering gases remain an active area of research,196–198 and
hydrogels capable of sensing gaseous metabolites are valuable
research tools.
There is currently only one strategy for materials that can
loosely be defined as delivery of oxygen in response to local
consumption. Perfluorocarbon (PFC) based materials, have
high oxygen solubility (up to 35 times the aqueous environ-
ment) and can act as oxygen conduits when the local partial
pressure drops. Hyaluronic acid hydrogels with a covalently
attached polyfluorinated oxadiazole have been shown to signifi-
cantly increase the viability of fibroblasts in both normoxic and
hypoxic conditions.199 Fluorinated methacrylamide chitosan
hydrogels have also shown enhanced oxygen distribution, and
higher fluorine content (via conjugation of longer fluorinated
chains) facilitated both the highest cell proliferation and
neuronal differentiation within neural progenitor cells.200
While no materials are currently able to truly respond to
gaseous metabolites and influence a cell, responsive hydrogels
that allow the imaging of gaseous metabolites still provide
significant information to tissue engineering and regenerative
medicine. For example, measuring the distribution of oxygen
within a tissue engineered construct can lead to better 3D
designs.201 For biological use, oxygen responsive probes (usually
organic dyes) are physically encapsulated in a hydrophobic poly-
mer or solid.202 Beautiful core–shell203 and dual-responsive204 (to
O2 and interleukin-6) hydrogels working on this principle have
already found application for tissue engineering. Recent efforts to
covalently incorporate porphyrin dyes into the hydrogel matrix,
has opened up the potential for hydrogel networks with immobi-
lized (non-leachable) dyes (as depicted in Fig. 8).205,206 Huang
et al. were even able to show the ability of a porphyrin crosslinked
PEG hydrogel to perform well as an implantable oxygen sensing
material,206 showing the possibility for long-term oxygen distribu-
tion imaging of tissue engineered constructs in vitro and in vivo.
7. Outlook
As we move towards more sophisticated hydrogel architectures,
the progress in stimuli responsive systems has the potential to
move from large, user generated stimuli, to smaller, locally
generated biological stimuli. The ability to engineer these
Fig. 8 Gas sensitive hydrogels have mainly been designed for imaging
applications. Proper concentrations of gaseous metabolites and by-
products within regenerating tissue is crucial for success, yet very difficult
to measure. Incorporating gas sensitive fluorophores (purple sphere) in the
hydrogel network allows the artificial environment to sense and provide
this information. For example, oxygen responsive Pd-porphyrins (left) have
been used to crosslink hydrogels for monitoring of oxygen concentration
subcutaneously.206
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hydrogel systems to listen and respond to cell-based stimuli
can pave the way to the creation of autonomous biomaterials to
be used in tissue engineering, drug delivery, sensing, and
cancer therapeutics, among other fields. With smart engineer-
ing and design, one can imagine the design of materials that
can not only recapitulate the real-time response of the natural
ECM, but also move towards multi-component207 systems that
provide non-natural or enhanced function,208 controlling the
growth, differentiation, and migration of cells towards the formation
of regenerated tissues. For example, the design of bioresponsive
hydrogels with complex logic gate functions has already been
demonstrated,209 and such logic gate architectures allow
complex responses from complex inputs.
The toolbox of chemistries to use in the design of cell-
responsive systems can be considered small, but more impor-
tantly, such chemistries are often poorly studied in the context
of complex biological systems. For example, supramolecular
biomaterials hold great promise to recreate and mimic the
complex and dynamic extracellular environment.26,66 Numerous
biological systems revolve around the dynamics, specificity,
responsiveness, and information richness of non-covalent
interactions and self-assembly for proper function.210 As we
grow more sophisticated in our engineering of synthetic supra-
molecular systems, demonstration of control over molecular
assembly pathways,211,212 energetics,213,214 consumption or
dissipation of energy,215–217 and the resultant dynamics,218,219
clustering,220,221 and function in a biological setting,66,67,222
have all been demonstrated. Control of dynamics can enable
the hydrogel to interact with different mechanosensing events,
clustering can effect signal transduction or raft formation via
superselective assembly, and control over pathways can enable
different environmental structures given different inputs.
Of particular interest, the creation of out-of-equilibrium and
dissipative self-assembled hydrogels will allow new insights
into the assembly of the natural ECM and the potential to
mimic this dynamic environmental switching in biorelevant
hydrogel systems.
As seen with CaM hydrogels (vide supra) molecular machines
can generate a large output from a simple biological signal.
Synthetic (supra)molecular machines, such as rotaxanes,223
catennanes,224 and molecular rotors225 have all gained much
recent attention due to recognition through the 2016 Nobel Prize.
These systems have a long road towards functional materials in a
complex environment, yet open up exciting new possibilities
Directed shuttling of nutrients and growth factors in a spatio-
temporal manner, and stimuli-generated mechanical forces, as
already seen in rotaxane molecular muscles,226 give scientists
the potential to go above and beyond some of the complexities
of natural ECM.
The use of dynamic covalent, protein/DNA engineered, and
enzyme degradable gels stand to provide good benchmarks for
fundamental development of hydrogel systems in the immediate
future. While dynamic covalent systems can specificity, their
synthetic accessibility and low cost (comparatively) render
them excellent choices for the production of larger amounts
of hydrogel for study. On the other hand, protein/DNA
engineered hydrogels allow ultimate levels of control and
biomimicry, but come at an extremely high price. Their repla-
cement by purely synthetic systems seems inevitable; however,
it must be noted that production of designed hydrogelators via
protein expression shows promise for scalability.227 Enzymati-
cally responsive hydrogels are excellent at creating remodelable
artificial environments, and are poised to remain a valuable
platform. Such systems are in need of new enzyme responsive
motifs and orthogonality between motifs to enable complex
functions such as complex signal processing and remodeling
via both degradation and creation.
A major driving force for the creation of hydrogels that can
respond to cellular signals or events has been the biochemical
and biophysical characterization of cellular behavior in space
and time. Marker identification, unravelling of signaling path-
ways, (bio)chemical quantification, and high content and
super-resolution microscopy techniques have all been para-
mount to measure the interplay between materials and cells.
When moving towards more dynamic systems, reliable cellular
readouts remain an ever present bottleneck to characterization.
Despite progress in spatio-temporal characterization of cells
and tissues, we still have a long way to go to understand the
different time scales that dominate cellular behavior and
decision making. While general timescales are known (e.g. cell
division normally takes 24 hours),228 the heterogeneity of time-
scales within populations and in signaling pathways is less
understood. Recent studies of time-dependant materials and
their effect on tissue engineering reinforce this importance.229,230
For example, the observation stem cells contain a ‘‘memory’’
for a few days for the stiffness of the substrate on which it
has been previously cultured231 clearly show the importance
of timescales for signaling pathways, adhesion formation,
differentiation, and homeostasis.
While it is the dream of many that a simple hydrogel
architecture will provide an effective surrogate for the natural
ECM or an instructive environment for tissue engineering, we
tend to think that replacement of such a multi-functional
environmental scaffold for cells can only be accomplished
effectively by multi-component complex chemical systems.
Complex, but not complicated. We support the idea that the
combination of simple chemical systems to work together in a
smart manner is the way forward for this, and potentially many
other fields.232
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W. J. A. Dhert, J. Groll and D. W. Hutmacher, Adv. Mater.,
2013, 25, 5011–5028.
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101 D. P. Nair, M. Podgórski, S. Chatani, T. Gong, W. Xi,
C. R. Fenoli and C. N. Bowman, Chem. Mater., 2013, 26,
724–744.
102 E. A. Phelps, N. O. Enemchukwu, V. F. Fiore, J. C. Sy,
N. Murthy, T. A. Sulchek, T. H. Barker and A. J. Garcı́a, Adv.
Mater., 2012, 24, 64–70.
103 K. Chwalek, M. V. Tsurkan, U. Freudenberg and C. Werner,
Sci. Rep., 2014, 4, 4414.
104 B. D. Mather, K. Viswanathan, K. M. Miller and T. E. Long,
Prog. Polym. Sci., 2006, 31, 487–531.
105 R. J. Wade, E. J. Bassin, W. M. Gramlich and J. A. Burdick,
Adv. Mater., 2015, 27, 1356–1362.
106 J. C. Grim, I. A. Marozas and K. S. Anseth, J. Controlled
Release, 2015, 219, 95–106.
107 L. A. Sawicki and A. M. Kloxin, J. Visualized Exp., 2016,
1–10.
108 L. Ouyang, C. B. Highley, W. Sun and J. A. Burdick, Adv.
Mater., 2017, 1604983.
109 S. Stichler, S. Bertlein, J. Tessmar, T. Jüngst and J. Groll,
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